Adolore Biotherapeutics, Inc.
PrivateLast Round
Convertible Debt
May 21, 2024
Total Funding Raised
$4M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Adolore Biotherapeutics, Inc. is a biotechnology company that develops non-opioid, locally-administered gene therapies for chronic pain and other neurological disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Adolore Biotherapeutics, Inc. Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Adolore Biotherapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Convertible Debt | May 21, 2024 | ||||
| Seed Round | Jan 25, 2024 | ||||
| Grant | Oct 3, 2023 | ||||
| Convertible Debt | Jan 13, 2022 |
Adolore Biotherapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH Helping to End Addiction Long-term (HEAL) Initiative | Grant |
| NIH HEAL Initiative | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 18, 2026
Monthly visitors increased 112% MoM, reaching 2K.
- Jan 25, 2024
$1.05M raised in Seed Round.
Adolore Biotherapeutics, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Adolore Biotherapeutics, Inc.'s valuation, stock price, and market status.